Results 211 to 220 of about 308,789 (237)

Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.

Anal Methods
Brennan LP, Hamacher F, Claure LA, Claure Dips AL, Sembian S, Balian LN, Piepho AD, Ermel AC, Linnes JC, Rodriguez NM.   +9 more
europepmc   +1 more source

Effect of coriolus versicolor-based vaginal gel on clearance of human papillomavirus and cervical dysplasia - a scoping review. [PDF]

BMC Womens Health
Højen IB, Kristensen MK, Bertelsen VM, Tranberg M, Petersen LK, Andersen B, Bor P.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Circulating HPV DNA in HPV-associated cancers

Clinica Chimica Acta, 2023
Human papillomavirus (HPV) infections are the primary cause of almost all cervical cancers, anal cancers, and a variable proportion of other anogenital tumors, as well as head and neck cancers. Circulating HPV DNA (cHPV-DNA) is emerging as a biomarker with extensive potential in the management of HPV-driven malignancies.
Guigao Lin, Jinming Li
openaire   +2 more sources

HPV and HPV-Associated Diseases

Infectious Disease Clinics of North America, 2013
Human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is associated with a significant burden of disease and cancer, including anogenital warts and recurrent respiratory papillomatosis, and anogenital and oropharyngeal cancers.
Eileen F, Dunne, Ina U, Park
openaire   +2 more sources

HPV vaccines

Best Practice & Research Clinical Obstetrics & Gynaecology, 2006
The ability to generate human papillomavirus virus (HPV)-like particles by the synthesis and self-assembly in vitro of the major virus capsid protein L1 has transformed our prospects for preventing cervical carcinoma in women. These particles provide vaccines that are immunogenic and safe, and data from proof-of-principle efficacy trials strongly ...
openaire   +2 more sources

Immunobiology of HPV and HPV vaccines

Gynecologic Oncology, 2008
Genital human papillomavirus (HPV) infection with both low- and high-risk types is common, but most infections resolve as a result of a cell-mediated immune response. Failure to induce an effective immune response is related to inefficient activation of innate immunity and ineffective priming of the adaptive immune response; this defective immune ...
openaire   +2 more sources

HPV and HPV‐associated cancer

Journal of Medical Virology, 2023
Xuefeng Liu, Nick Wallace
openaire   +2 more sources